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Abstract 
Anorexia nervosa (AN) is found associated with increased mortality. Frequent comorbidities 
of AN include substance use disorders (SUD), affective disorders (AD) and personality 
disorders (PD). 
We investigated the influence of these psychiatric comorbidities on all-cause mortality with 
demographic and socioeconomic factors considered as confounders in the observation 
window between January 2007 and March 2016 for 1,970 people with AN, using data from 
the case register of the South London and Maudsley (SLaM) NHS Foundation Trust, an 
almost monopoly secondary mental healthcare service provider in southeast London. We 
retrieved data from its Clinical Records Interactive Search (CRIS) system as data source. 
Mortality was ascertained through nationwide tracing by the UK Office for National Statistics 
(ONS) linked to CRIS database on a monthly basis. 
A total of 43 people with AN died during the observation period. Standardized Mortality 
Ratio (SMR) with England and Wales population in 2012 as standard population for our 
study cohort was 5.21 (95% CI: 3.77, 7.02). In univariate analyses, the comorbidity of SUD 
or PD was found to significantly increase the relative risks of mortality (HRs=3.10, 95% CI: 
1.21, 7.92; and 2.58, 95% CI: 1.23, 5.40, respectively). After adjustment for demographic and 
socioeconomic covariates as confounders, moderately but not significantly elevated risks 
were identified for SUD (adjusted HR=1.39, 95% CI: 0.53, 3.65) and PD (adjusted HR=1.58, 
95% CI: 0.70, 3.56). 
These results suggest an elevated mortality in people with AN, which might be, at least 
partially, explained by the existence of the comorbidities SUD or PD. 
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Introduction 
Anorexia nervosa 
Anorexia nervosa (AN) is defined by a significantly low body weight in the context of age, 
sex, and physical health, intense fear of weight gain and disturbed body perception [1]. The 
number of people with AN is rising, and the illness is affecting people at an increasingly 
younger age [2-4]. The prevalence of AN is between less than 1% and 4% among women, 
with a male:female ratio of approximately 1:10 [5]. The peak age of incidence is between 14 
and 17 years old [6]. 
 
Mortality for people with AN 
Dietary deficit is often accompanied by significant physical health issues, including growth 
retardation, osteopenia, osteoporosis, amenorrhoea, renal insufficiency, and changes in 
laboratory parameters, cardiac arrhythmia and disturbances of the thyroid function [7]. The 
most common causes of death in people with AN are sudden cardiac death associated with 
ventricular arrhythmias, and suicide [8-10]. Mortality rates are five to six times higher for 
people with AN than in the general population, and in people aged 15–24 years old, the 
mortality risk from AN is higher than for other serious diseases in adolescence, like asthma or 
type 1 diabetes [3, 4]. 
 
Mental health comorbidities in AN as risk factors for mortality 
AN is often accompanied by other mental disorders, including substance use disorders (SUD) 
[11], affective disorders (AD) [12, 13] and personality disorders (PD) [14]. In the Swedish 
Twin Registry, people with AN exhibited a significantly increased risk for the use of alcohol 
and illicit drugs, specifically diet pills and stimulants [11]. Another Swedish study which 
evaluated data from patients presenting to specialist eating disorder clinics between 2008 and 
2012 found that 521 (38.8%) of 1,343 patients with AN suffered from AD, principally 
unipolar depression [12]. A German investigation in female inpatients with AN reported a 
prevalence of around 30% for one or more comorbid PDs [14]. In this study, comorbid PD 
was found related to a worse treatment outcome. Potential comorbidities of AN including 
addiction to alcohol [15, 16] or illicit drugs [17], unipolar depression [18] and PD [19] have 
been found to be associated with increased mortality. In a recent retrospective Swedish 
register study investigating mortality in women with AN, SUDs and depression significantly 
contributed to mortality, but not PDs [20]. 
Other important risk factors contributing to mortality in people with mental disorders include 
age, gender, marital status, socioeconomic deprivation and ethnicity [21-27]. However, these 
risk factor influence mortality in people with physical diseases, too [28-30]. Therefore, they 
seem to be general factors which modify mortality. 
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Comparable studies, e.g. Kask et al. [20, 31] only covered patients aged 10 to 40 years. 
Therefore, results of these studies may not be generalizable to all age groups. We decided not 
to set an age limit to achieve a comprehensive epidemiologic view on mortality of patients 
with AN. Moreover, there are case reports of patients newly diagnosed with AN at the age of 
65 or older [32], and a recent study demonstrated that active eating disorders are common 
amongst women in mid-life, both due to new onset and chronic disorders [33]. 
 
General aspects of mortality in patients with mental disorders 
When thinking about psychiatric comorbidity as a risk factor for mortality in people with AN, 
it seems sensible to take some important general aspects of mortality in patients with mental 
disorders into account. According to a recent systematic review and meta-analysis including 
203 eligible articles and representing 29 countries in 6 continents, mortality is significantly 
higher among people with mental disorders than among the comparison population. About 
two thirds of deaths among people with mental disorders are due to natural, about 18% to 
unnatural, and the remainder to other or unknown causes. The median years of potential life 
lost was found to be 10 years, and it was estimated that around 14% of deaths worldwide (8 
million deaths each year) are attributable to mental disorders [34]. Important overall risk 
factors contributing to mortality in patients with mental disorders include sociodemographic 
variables such as age, gender, ethnicity, unemployment and low educational attainment, 
physical diseases such as cancer and coronary heart disease, the specific psychiatric diagnosis 
and additional other psychological and behavioural problems like substance abuse and 
dependence; unnatural and alcohol-related causes of death seem to play a specific role for 
increased mortality in younger age groups of people with mental disorders [35-38]. 
 
Aim of the study 
In this study, we sought to investigate the influence of major psychiatric comorbidities on all-
cause mortality in people with AN in a case register for a large secondary mental healthcare 
service provider in southeast London, UK, with confounding from demographic and 
socioeconomic factors considered. Our hypothesis for this investigation was that AD, SUD 
and PD had an independent effect on increased mortality in people with AN. 
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Methods 
Setting and study design 
A retrospective cohort study was performed in people with AN. The AN cohort was obtained 
from the South London and Maudsley NHS Foundation Trust (SLaM) which provides near-
monopoly secondary mental healthcare services to a geographic catchment of about 1.36 
million residents in southeast London. SLaM’s Eating Disorders Service additionally offers a 
specialist tertiary service for service users across the UK. Patients included in this study 
mainly resided in the London boroughs of Lambeth, Croydon, Lewisham, Southwark, 
Bromley, Bexley and Greenwich. The SLaM National Institute for Health Research 
Biomedical Research Centre (BRC) supports the infrastructure for research of anonymised 
electronic clinical records from SLaM’s case register, using the BRC’s Clinical Record 
Interactive Search (CRIS) system as data source, established in 2008 [39, 40]. 
 
Inclusion criteria and primary exposure 
The analyzed cohort was extracted via CRIS, consisting of individuals who had received an 
International Classification of Diseases (ICD-10) diagnosis [41] of AN (F50.0/F50.1) within 
or before the observation window from 1 January 2007 to 31 March 2016. Structured 
information on diagnosis from drop-down fields in the source record was supplemented by 
information extracted from open-text fields using a bespoke algorithm generated by using the 
Generalised Architecture for Text Engineering (GATE) software [39]. The exposure of 
interest was a further diagnosis of SUD (F10–F19), AD (F31-33) or PD (F60) at any stage 
during or before the observation window extracted from CRIS using identical procedures. 
 
Primary outcome 
The outcome of this analysis was all-cause mortality occurring from January 2007 to March 
2016. Information about each death was collected through nationwide tracing using data from 
the UK Office for National Statistics (ONS) linked to the SLaM database on a monthly basis. 
In the UK, all death certifications are linked by NHS number (a unique identifier for each UK 
NHS service user) to all healthcare providers. 
 
Covariates 
Date of birth (for year and month), gender, ethnicity, marital status and residing borough were 
retrieved from the CRIS database. Age in years was calculated from the individual’s first AN 
diagnosis date in the observation period or on 1 January 2007 if the AN diagnosis preceded 
the observation period. 
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Recorded ethnicity was classified into three categories: ‘white’ (including ‘British’, ‘any 
other white background’ and ‘Irish’), ‘black’ (including ‘African’, ‘any other black 
background’ and ‘Caribbean’), and ‘others/unknown/mixed’. Recorded marital status was 
classified into four groups: ‘married’ (including ‘cohabitation’, ‘married’ and ‘married/civil 
partnership’), ‘single’, ‘divorced’ (including ‘divorced/ civil partnership dissolved’, 
‘separated’), and ‘others’. Borough was classified by the subject’s residence: Lambeth, 
Croydon, Lewisham, Southwark, Bromley, Bexley and Greenwich, defined by their primary 
care trust. Multiple deprivation score is a small-area-level measure of socioeconomic status 
derived from UK Census data, based on the individual’s address closest to the diagnosis of 
AN in the observation window (or 1 January 2007 for those with an earlier diagnosis of AN), 
covering the seven components, ‘employment’, ‘income’, ‘education’, ‘health’, ‘barriers to 
housing and services’, ‘crime’ and ‘living environment’, with specific weightings. The Index 
of Multiple Deprivation score is a well-established measure which has been widely used as a 
regional indicator for socioeconomic status in previous studies [42-44]. The score is then 
transformed into percentiles (from 1 to 100) with a higher score indicating greater deprivation 
(and thus lower socioeconomic status in the neighbourhood). In the analysis, deprivation 
scores were regrouped by tertiles (33.3 percentiles). 
 
Ethical approval 
Ethical approval was obtained from the Oxfordshire Research Ethics Committee C for the use 
of CRIS as a source of data for secondary analysis (reference 08/H0606/71+5) including the 
mortality linkage. The study has been performed in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki and its later amendments. 
 
Statistical analysis 
Standardized Mortality Ratio (SMR) was used for the adjustment of age and gender structure, 
comparing our study cohort to a standard population for mortality. Observed number of death 
in the window was treated as the numerator of SMR in the calculation. Age spanning in 5-
year age and sex bands were then utilized to define age- and gender-specific groups in our 
study cohort. Denominator of SMR was the sum of expected numbers for age-and-sex bands 
derived by the number of people in individual band in our study cohort multiplying its 
corresponding age- and gender-specific mortality rate in the general population of England 
and Wales in 2012 according to ONS data. Since the study cohort was followed up for up to 
9.25 years but mortality rates for the general population were given for a year only, specific 
weightings based on the average follow-up period for corresponding age-and-sex bands for 
the calculation of SMR’s denominator were applied. 
Descriptive statistics on demographic characteristics and psychiatric comorbidities were first 
carried out for the study cohort. We then used Cox proportional hazards regression to 
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estimate the effect for each of the variable by hazard ratio (HR) with a 95% confidence 
interval (CI) on death as the ‘event’ of interest within the observation window. Beginning of 
the follow-up period was defined as the start of the observation window (1 January 2007) if 
the first diagnosis was given before the window, otherwise the beginning was taken as the 
date of first AN diagnosis given in the window. Multivariate analyses were lastly performed 
in parallel to estimate the effect of the considered psychiatric comorbidities as major 
exposure of interest, controlling for confounding of age, sex, ethnicity, borough, marital 
status and deprivation score. All the statistical analyses were performed using Stata 12.1 
(StataCorp, College Station, Texas, USA) and the statistical significance (alpha level) was set 
at 0.05. 
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Results 
Descriptive statistics 
A total of 1,970 individuals diagnosed with AN were identified from the CRIS system. 
Among them, 1,834 were female and 136 were male. The mean age was 24.5 years old 
(standard deviation: 11.3 years; range 8 to 88 years old). Twelve (0.6%) patients with AN 
were 65 years old or older. More detailed information about age distribution was put in Table 
1. During the observation window, 43 of the 1,970 study subjects died. Descriptive statistics 
are shown in detail in Table 2. 
 
Standardized mortality ratio (SMR) 
Age- and gender-SMR for our study cohort was 5.21 (95% CI: 3.77, 7.02), with the 
population of England and Wales in 2012 as standard population according to ONS data on 
its website. 
 
Univariate analysis by Cox regressions 
Cox regressions revealed a significant effect of age, marital status, deprivation score, SUD 
and PD. Specifically, older age, being separated or divorced, being deprived and suffering 
from comorbidity of SUD and PD were associated with a higher mortality risk (details shown 
in Table 2). The mean age of the patients who died in the observation window was 41.03 
years old (standard deviation=18.36 years; ranging from 15 to 86 years old), whereas the 
mean age of patients who survived was 24.11 years old (standard deviation=10.79 years; 
ranging from 8 to 88 years old). 
 
Multivariate analyses by Cox regressions 
Controlling for age, sex, ethnicity, the residing borough, marital status and deprivation score 
as confounders, multivariate analysis outcomes by Cox regression is shown in Table 3. 
Significance of the comorbidities to mortality in people with AN disappeared, when 
controlling for potential confounders. However, moderately elevated risks were identified for 
SUD (adjusted HR=1.39, 95% CI: 0.53, 3.65) and PD (adjusted HR=1.58, 95% CI: 0.70, 
3.56). All detailed information regarding multivariate analyses outcomes for AD, SUD and 
PD as the major exposure of interest was separately presented in Supplementary Tables 1-3. 
9 
 
Discussion 
Main findings 
In summary, 43 of the 1,970 people with AN died during the observation period of more than 
nine years. A more than five folds of general mortality was found by age and gender 
standardization, compared to the general population in England and Wales. Moderately 
elevated mortality risks were estimated for comorbid SUD and PD with confounders 
controlled, but not significant because of power issues. 
 
Comparison to previous research 
The SMR in our study cohort is comparable to previous studies, reporting that patients with 
AN have five to six times higher mortality than the general population [3, 4]. However, there 
are also studies reporting even higher all-cause mortality rates [20, 31], but these studies 
included inpatients only. One can assume that inpatient status reflects a higher degree of 
severity. 
In a recent meta-analysis of mortality studies in AN [45], age was – apart from the applied 
diagnostic criteria – the most significant factor influencing mortality. The finding that age and 
social deprivation significantly influence mortality is also in accordance with Franko et al. 
[46] who investigated 246 treatment-seeking women with AN or bulimia nervosa 
longitudinally, among them 136 patients with AN. However, in contrast to Franko et al., we 
could not replicate their finding of a significant contribution of alcohol abuse to all-cause 
mortality in AN. 
Considering sample size, data characteristics and the link between a clinical register and a 
death register, our study seems to be most comparable to the Swedish register studies where 
the Swedish Hospital Discharge Register is linked to the Swedish Cause-of-Death Register. 
The latest comparable Swedish studies investigated mortality in 8,069 female inpatients [20] 
and 609 males who received hospitalized care for AN [31]. Both studies found that SUD 
significantly contributed to mortality. These two studies included only patients aged 10 to 40 
years to minimize the risk of incorrect diagnoses [20, 31]. In contrast, our study included 
patients with AN at all ages. If we look at SUD across the age range, SUD are most prevalent 
and most important between 10 to 40 years of age [47, 48]. Therefore, results of these two 
studies by Kask et al. may not be generalizable to all age groups of patients with AN [20, 31]. 
We decided not to set an age limit for inclusion of people in our study for three reasons. First, 
we sought to achieve a comprehensive epidemiologic view on mortality of patients with AN. 
One should keep in mind though, while interpreting the results of our study, that a diagnosis 
of AN did neither require that AN was the leading current diagnosis nor that it was the first 
episode of AN. Second, current research has highlighted the occurrence of AN in mid-life and 
older adults [32, 33, 49]. Third, studies in AN have used different upper age limits, for 
example, 40 years of age [20, 31], even though other studies have shown that in a relevant 
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proportion of people with AN is first diagnosed or first treated after the age of 40 [32, 33]. 
For that reason, imposing a specific age limit seemed arbitrary. 
Moderately elevated mortality risks were identified for SUD and PD in people with AN in 
our analysis, although not significant. Besides the issue of potentially insufficient statistical 
power, marital status might work as a critical mediator within the causal pathway between 
AN and mortality, taking away the effect from AN to mortality in the effect estimation by 
multivariate analysis. However, when we put marital status away from the final model, the 
outcomes for PD and SUD comorbidity did not change dramatically. Thus, the possibility of a 
mediating role for marital status seems limited. 
 
Strengths and limitations 
The main strengths of this study were the study design and size of cohort by using CRIS as 
our data source. CRIS is one of the largest collections of secondary and tertiary mental 
healthcare services. By using this data in a retrospective cohort study, we identified a large 
number of 1,970 patients with AN. However, in the observation period, only 43 patients with 
AN died, resulting in limited statistical power. The research outcomes of this study might be 
only generalizable to secondary and tertiary health care settings, but not to people with AN in 
community. In terms of generalizability, we also should be cautious that diagnoses were 
coded according to ICD-10 [41] which is still the currently used classification in the UK. 
Nevertheless, it needs to be mentioned that criteria have slightly changed in DSM-5 [1]. 
In principle, using data derived from secondary and tertiary mental healthcare services may 
potentially lead to an overestimation of the effect of a certain disorder on mortality and might 
compromise generalizability. The potential reasons for this assumption are that some patients 
with the disorder in question may not be under the care of any health service, and some of 
those cared for in primary care might not be referred to a specialist service. Thus, those who 
are referred to a specialist service might be more severely affected than the whole group of 
patients with this specific disorder.  
However, studies which have successfully ascertained prevalence and service use rates in AN 
are scarce due to the relatively low prevalence of AN compared to other eating disorders. For 
example, a study by Solmi et al. [50] which examined 1,698 individuals between 16 and 90 
years of age in southeast London found a point prevalence of eating disorders of 4.4%, but no 
cases of AN at all. Thus, this study was unable to gauge service use among patient with AN. 
A US-American study found prevalence rates of AN between 0.03% and 0.39% and service 
utilization rates of patients with AN between 30% and 100% depending on the ethnicity of 
patients [51]. For non-Latino white patients with AN service use rates were around 76% [51]. 
White people are currently the biggest ethnic group in London [52] and in our study sample 
(see Table 2). Therefore, we can assume a similarly high service use rate for our patients. 
Nevertheless, we are aware of the ongoing debate whether general practitioners are good or 
poor at identifying the eating disorders [53]. 
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It is likely that most patients presenting with AN to primary care in the UK are referred on to 
secondary care, including both general mental health services and specialist eating disorder 
services [54], because previous [54] and current [55] guidelines of The National Institute for 
Health and Care Excellence (NICE) in the UK advise general practitioners to refer anyone 
with a suspected eating disorder to specialist services without delay. 
As information about each death was obtained through nationwide tracing using ONS, data 
on mortality are very reliable. A failure to obtain death data would appear, if people left the 
country during the observation period and died abroad. Such an event could have led to a 
failure to register the death of a patient with AN treated in SLaM. 
Overall, we think that CRIS data on the diagnosis of AN and on mortality are generalizable, 
because we assume – based on the limited evidence available – that most patients with AN 
seek medical help and are referred to secondary mental healthcare services [51, 53], and 
SLaM is an almost monopoly secondary mental healthcare service provider in southeast 
London. As we can assume that our data on the diagnosis of AN and on the cases of death are 
reliable, we think that the obtained SMR for our study cohort of 5.21 is accurate. 
Compared to other studies [11-14, 56, 57] we obtained relatively low rates of comorbid SUD, 
AD and PD in patients with AN. Thus, these disorders may have been underdiagnosed in our 
study sample, and underdiagnosis could be a source of error. When drawing further 
conclusions from our data, one must keep in mind that our data on SUD, AD and PD were not 
collected whilst specifically searching for these diagnoses. Instead, these diagnoses were 
documented by clinicians when clinically relevant. Therefore, our results cannot be easily 
compared with studies in which researchers used questionnaires and diagnostic tools to 
specifically detect SUDs, ADs or PDs. 
Another important limitation of our investigation is that we were not able to consider the 
subtypes of AN (binge/purge vs. restrictive), illness severity and duration, the number of 
hospital admissions during the observation period and the body mass index (BMI) which 
have all been found to contribute to mortality of people with AN in previous studies [46, 58-
61]. As what already mentioned before, we do not know, when the diagnosis was first 
established in participants of this study. 
 
Future research directions 
For this particular project, the date of death, but not the cause of death was available from the 
ONS. The causes of death could be physical consequences of AN like ventricular arrhythmias 
or suicide [8-10]. Future research could shed more light on the specific causes of death as the 
consequence of AN. 
Further studies should also focus on modifiable risk factors for premature death prevention. 
Given a significant contribution of social deprivation to all-cause mortality, the question 
12 
 
arises whether a reduction of mortality can be achieved by interventions intending to tackle 
social deprivation, like family therapy, social work, social inclusion therapy and debt advice. 
We have found an alarmingly increased mortality in patients with AN compared to the 
general population in accordance with previous studies [3, 4, 20, 31]. Thus, the question 
arises, whether the increased mortality can, in principle, be influenced by the available 
therapies. However, scientific knowledge on long-term treatment outcomes of most the 
various psychotherapeutic, refeeding and psychopharmacological approaches in AN is scarce 
[61, 62], and we know even less about whether these therapies can reduce mortality. 
Psychotherapy can have side effects such as the emergence of new symptoms, the 
deterioration of existing symptoms, dependence and regression, traumatic stress, strains or 
changes in family or work relations and missing the chance to seek suitable medical treatment 
[63, 64]. This is interesting considering our findings that being separated or divorced and 
being deprived in the sense of a lower socioeconomic status contribute to mortality in AN. 
Thus, future research could investigate whether specific therapies influence the occurrence of 
additional psychiatric symptoms and risk factors in a favourable or in an unfavourable way. 
We can assume a widespread use of medications like olanzapine during inpatient treatment 
for AN (for example [65]). Moreover, most patient with AN want and request medication to 
help with anxiety, sleep problems and pain [66, 67]. However, there is almost no evidence for 
the effects of pharmacological treatment in AN due to a lack of randomized controlled trials 
[68] – apart from a few studies with promising results such as [69]. The effect of 
psychopharmacological treatment on mortality is also unknown in AN. Due to potential side 
effects such as electrolyte imbalances and abnormalities of the heart rhythm [70], mortality 
might even increase in patients with AN during treatment with these medications. 
Taken together, potential future research directions to further explore and complement the 
findings of the present study include the investigation of the specific causes of death, physical 
risk factors of mortality in patients with AN and the effects of psychotherapeutic, nutritional 
and psychopharmacological therapies on mortality. 
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Table 1. Age distribution of study participants (N=1,970) 
Age group 
(years) Frequency Percent 
5-10 4 0.20 
10-15 284 14.42 
15-20 602 30.56 
20-25 375 19.04 
25-30 255 12.94 
30-35 152 7.72 
35-40 100 5.08 
40-45 64 3.25 
45-50 47 2.39 
50-55 33 1.68 
55-60 29 1.47 
60-65 13 0.66 
65-70 4 0.25 
70-75 2 0.10 
75-80 3 0.15 
80-85 0 0.00 
85-90 2 0.10 
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Table 2. Univariate analysis on demographics and clinical characteristics for mortality among 
people with people with anorexia nervosa by Cox regressions (N = 1,970) 
Variables 
Mean ± SD / Numbers 
(% in column) 
Number of deaths 
(% in row) 
Hazard Ratio 
(95% CI) p-value 
Age (years old) 24.48 ± 11.27 -- 1.08 (1.06, 1.10)* <0.01 
Gender 
Female 
Male 
 
1,834 (93.10%) 
136 (6.90%) 
 
39 (2.13%) 
4 (2.94%) 
 
Ref 
1.33 (0.47, 3.71) 
 
 
0.59 
Marital Status 
Single 
Married/Partner 
Divorced/Separated 
Others 
 
1,532 (77.77%) 
175 (8.88%) 
43 (2.18%) 
220 (11.17%) 
 
24 (1.57%) 
6 (3.43%) 
3 (6.98%) 
10 (4.55%) 
 
Ref 
2.12 (0.87, 5.19) 
3.75 (1.13, 12.48)* 
2.35 (1.12, 4.93)* 
 
 
0.10 
<0.05 
<0.05 
Borough 
Lambeth 
Croydon 
Lewisham 
Southwark 
Bromley 
Bexley 
Greenwich 
Others 
 
298 (15.13%) 
237 (12.03%) 
217 (11.02)% 
219 (11.12%) 
253 (12.84) 
114 (5.79%) 
103 (5.23%) 
529 (26.85%) 
 
3 (1.01%) 
8 (3.38% 
4 (1.84%) 
7 (3.20%) 
5 (1.98%) 
4 (3.51%) 
2 (1.94%) 
10 (1.89%) 
 
Ref 
2.61 (0.69, 9.85) 
1.57 (0.35, 7.03) 
2.89 (0.75, 11.17) 
1.87 (0.45, 7.81) 
3.15 (0.71, 14.09) 
1.83 (0.30, 10.93) 
1.72 (0.47, 6.24) 
 
 
0.16 
0.55 
0.12 
0.39 
0.13 
0.51 
0.41 
Ethnicity 
White 
Black 
Others/Mixed 
 
1,639 (83.20%) 
63 (3.20%) 
268 (13.60%) 
 
34 (2.07%) 
2 (3.17%) 
7 (2.61%) 
 
Ref 
1.27 (0.30, 5.28) 
1.27 (0.56, 2.87) 
 
 
0.74 
0.56 
Deprivation Score a 
1.14-17.60 
17.61-29.17 
29.18-100 
Missing/homeless 
 
644 (32.69%)  
643 (32.64%) 
645 (32.74%) 
38 (1.93%) 
 
10 (1.55%) 
10 (1.56%) 
22 (3.41%) 
1 (2.63%) 
 
Ref 
0.92 (0.38, 2.22) 
2.12 (1.01, 4.50)* 
1.37 (0.17, 10.69) 
 
 
0.86 
<0.05 
0.77 
SUD 
No 
Yes  
 
1,909 (96.90%) 
61 (3.10%)  
 
38 (1.99%) 
5 (8.20%) 
 
Ref 
3.10 (1.21, 7.92)* 
 
 
<0.05 
AD 
No 
Yes  
 
1,680 (85.28%) 
290 (14.72%)  
 
34 (2.02%) 
9 (3.10%) 
 
Ref 
1.40 (0.67, 2.93) 
 
 
0.37 
PD 
No 
Yes 
 
1,798 (91.27%) 
172 (8.73) 
 
34 (1.89%) 
9 (5.23%) 
 
Ref 
2.58 (1.23, 5.40)* 
 
 
<0.05 
 
Abbreviations: Substance use disorder (SUD), affective disorder (AD), personality disorder 
(PD), statistically significant according to a level of significance of 0.05 (*). Further 
information (a): Higher deprivation scores indicate greater deprivation and thus lower 
socioeconomic status. 
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Table 3. Multivariate analysis on demographics and clinical characteristics for mortality 
among people with anorexia nervosa by Cox regressions, controlling age, sex, ethnicity, 
borough, marital status and deprivation score (N = 1,970) 
 
Comorbidity 
Adjusted Hazard Ratio 
(95% CI) p-value 
AD 0.80 (0.36, 1.81) 0.60 
SUD 1.39 (0.53, 3.65) 0.50 
PD 1.58 (0.70, 3.56) 0.27 
Abbreviations: Substance use disorder (SUD), affective disorder (AD), personality disorder (PD). 
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Supplementary Materials 
Supplementary Table 1. Multivariate analysis for AN people with SUD as the major exposure 
of interest controlling demographics and characteristics of clinical profile among as potential 
confounders on mortality by Cox regression (N = 1,970) 
Variables 
Hazard Ratio 
(95% CI) p-value 
Age (years old) 1.08 (1.06, 1.10)* <0.01 
Gender 
Female 
Male 
 
Ref 
2.00 (0.33, 2.97) 
 
 
0.99 
Marital Status 
Single 
Married/Partner 
Divorced/Separated 
Others 
 
Ref 
0.56 (0.21, 1.53) 
1.10 (0.31, 3.90) 
1.33 (0.58, 3.03) 
 
 
0.26 
0.89 
0.50 
Borough 
Lambeth 
Croydon 
Lewisham 
Southwark 
Bromley 
Bexley 
Greenwich 
Others 
 
Ref 
3.19 (0.81, 12.49) 
2.15 (0.47, 9.72) 
2.82 (0.71, 11.18) 
3.76 (079, 17.97) 
6.66 (1.32, 33.53)* 
2.60 (0.42, 6.18) 
2.64 (0.67, 10.34) 
 
 
0.10 
0.32 
0.14 
0.10 
<0.05 
0.31 
0.16 
Ethnicity 
White 
Black 
Others/Mixed 
 
Ref 
1.30 (0.30, 5.63) 
1.53 (0.65, 3.63) 
 
 
0.73 
0.33 
Deprivation Score a 
1.14-17.60 
17.61-29.17 
29.18-100 
Missing/homeless 
 
Ref 
1.09 (0.41, 2.90) 
2.30 (0.91, 5.80) 
2.30 (0.27, 19.81) 
 
 
0.86 
0.08 
0.45 
SUD 
No 
Yes  
 
Ref 
1.39 (0.53, 3.65) 
 
 
0.50 
Abbreviations: Substance use disorder (SUD), statistically significant according to a level of 
significance of 0.05 (*). Further information (a): Higher deprivation scores indicate greater 
deprivation and thus lower socioeconomic status. 
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Supplementary Table 2. Multivariate analysis for AN people with AD as the major exposure 
of interest controlling demographics and characteristics of clinical profile among as potential 
confounders on mortality by Cox regression (N = 1,970) 
Variables 
Hazard Ratio 
(95% CI) p-value 
Age (years old) 1.08 (1.06, 1.11)* <0.01 
Gender 
Female 
Male 
 
Ref 
1.03 (0.35, 3.06) 
 
 
0.95 
Marital Status 
Single 
Married/Partner 
Divorced/Separated 
Others 
 
Ref 
0.56 (0.21, 1.51) 
1.09 (0.31, 3.87) 
1.30 (0.57, 2.97) 
 
 
0.25 
0.31 
0.54 
Borough 
Lambeth 
Croydon 
Lewisham 
Southwark 
Bromley 
Bexley 
Greenwich 
Others 
 
Ref 
3.40 (0.85, 13.63) 
2.14 (0.47, 9.68) 
2.81 (0.71, 11.08) 
3.77 (0.79, 17.97) 
6.38 (1.28, 31.86)* 
2.44 (0.39, 15.19) 
2.60 (0.67, 10.11) 
 
 
0.09 
0.32 
0.14 
0.10 
<0.05 
0.34 
0.17 
Ethnicity 
White 
Black 
Others/Mixed 
 
Ref 
1.23 (0.28, 5.35) 
1.49 (0.63, 3.53) 
 
 
0.78 
0.36 
Deprivation Score a 
1.14-17.60 
17.61-29.17 
29.18-100 
Missing/homeless 
 
Ref 
1.09 (0.41, 2.90) 
2.38 (0.95, 5.97) 
2.32 (0.27, 19.94) 
 
 
0.86 
0.06 
0.45 
AD 
No 
Yes  
 
Ref 
0.80 (0.36, 1.81) 
 
 
0.60 
Abbreviations: Affective disorder (AD), statistically significant according to a level of 
significance of 0.05 (*). Further information (a): Higher deprivation scores indicate greater 
deprivation and thus lower socioeconomic status. 
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Supplementary Table 3. Multivariate analysis for AN people with PD as the major exposure of 
interest controlling demographics and characteristics of clinical profile among as potential 
confounders on mortality by Cox regression (N = 1,970) 
Variables 
Hazard Ratio 
(95% CI) p-value 
Age (years old) 1.08 (1.06, 1.10)* <0.01 
Gender 
Female 
Male 
 
Ref 
1.11 (0.37, 3.33) 
 
 
0.85 
Marital Status 
Single 
Married/Partner 
Divorced/Separated 
Others 
 
Ref 
0.58 (0.22, 1.58) 
1.02 (0.29, 3.64) 
1.25 (0.54, 2.88) 
 
 
0.29 
0.98 
0.61 
Borough 
Lambeth 
Croydon 
Lewisham 
Southwark 
Bromley 
Bexley 
Greenwich 
Others 
 
Ref 
2.87 (0.73, 11.34) 
1.98 (0.44, 9.00) 
2.58 (0.65, 10.31) 
3.71 (0.78, 17.76) 
6.65 (1.32, 33.48)* 
2.50 (0.40, 15.52) 
2.48 (0.63, 9.68) 
 
 
0.13 
0.38 
0.18 
0.10 
<0.05 
0.32 
0.19 
Ethnicity 
White 
Black 
Others/Mixed 
 
Ref 
1.23 (0.28, 5.34) 
1.61 (0.68, 3.85) 
 
 
0.78 
0.28 
Deprivation Score a 
1.14-17.60 
17.61-29.17 
29.18-100 
Missing 
 
Ref 
1.09 (0.41, 2.92) 
2.27 (0.90, 5.75) 
2.25 (0.26, 19.42) 
 
 
0.86 
0.08 
0.46 
PD 
No 
Yes 
 
Ref 
1.58 (0.70, 3.56) 
 
 
0.27 
Abbreviations: Personality disorder (PD), statistically significant according to a level of 
significance of 0.05 (*). Further information (a): Higher deprivation scores indicate greater 
deprivation and thus lower socioeconomic status. 
